[Federal Register: July 23, 2001 (Volume 66, Number 141)]
[Notices]
[Page 38282-38283]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23jy01-73]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 01146]
Expansion of HIV/AIDS Prevention Activities in the Republic of
Kenya; Notice of Availability of Funds
A. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2001 funds for a cooperative agreement
program for Global AIDS Program.
The purpose of the program is to provide assistance in developing a
disease Surveillance program for the control of HIV/AIDS in the country
of Kenya, and to support activities to reduce the burden of
tuberculosis.
B. Eligible Applicants
Single Source
Assistance will be provided only to the Ministry of Health (MOH) of
the Country of Kenya. No other applications are solicited.
This announcement is restricted to the MOH or subservient agencies
of the government of Kenya as they are the only legislated entity with
the authority and responsibility to collect such data for the purpose
of the control of HIV/AIDS, communicable disease and the maintenance of
public health.
A. Availability of Funds
Funds are available under this announcement to fund two specific
activities with funding amounts identified for each activity. These
activities are:
1. HIV/AIDS Surveillance Activities including:
(a) Monitoring of Blood Safety
(b) Overall monitoring of HIV VCT and Mother to Child Transmission
within Kenya--$500,000
2. Tuberculosis Surveillance and Control as it relates to HIV/
AIDS--$1 million
Each component or program activity for which funds are requested
should be specifically identified with Goals, Plan, Objectives,
Activities, Method of Evaluation and budget provided. A summary budget
by line item should be provided.
It is expected that the awards will begin on or about September 30,
2001 and will be made for a 12-month budget period within a project
period of up to five (5) years. Funding estimates may change.
Continuation awards within an approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
Use of Funds
Antiretroviral Drugs
Funds received from this announcement will not be used for the
purchase of antiretroviral drugs for treatment of established HIV
infection (with the exception nevirapine in PMTCT cases and with prior
written approval), occupational exposures, and non-occupational
exposures and will not be used for the purchase of machines and
reagents to conduct the necessary laboratory monitoring for patient
care.
Applicants may contract with other organizations under these
cooperative agreements, however, applicants must perform a substantial
portion of the activities including program management and operations
and delivery of prevention services for which funds are requested.
The costs that are generally allowable in grants to domestic
organizations are likewise allowable to foreign institutions and
international organizations, with the following exceptions:
Indirect Costs: With the exception of the American University,
Beirut, the Gorgas Memorial Institute, and the World Health
Organization, indirect costs will not be paid (either directly or
through a sub-award) to organizations located outside the territorial
limits of the United States or to international organizations
regardless of their location.
All requests for funds, including the budget contained in the
application, shall be stated in U.S. dollars. Once an award is made,
the Department of Health and Human Services (DHHS) will not compensate
foreign grantees for currency exchange fluctuations through the
issuance of supplemental awards.
Needle Exchange
No funds appropriated under this Act shall be used to carry out any
program of distributing sterile needles or syringes for the hypodermic
injection of any illegal drug.
[[Page 38283]]
D. Where to Obtain Additional Information
This and other CDC announcements can be found on the CDC home page
Internet address--http://www.cdc.gov. Click on ``Funding'' then
``Grants and Cooperative Agreements.''
To obtain business management technical assistance, contact:
Dorimar Rosado, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-4146,
Telephone number (770) 488-2782, E-mail address: dpr7@cdc.gov.
For program technical assistance, contact: Lawrence H. Marum, M.D.,
FAAP, MPH, CDC LIFE Initiative P.O. Box 30137, Nairobi, National AIDS/
ASTD Control Programme (NASCOP), P.O. Box 30137, Nairobi, Kenya.
US Mail: Unit 64112, APO, AE 09831-4112, Telephone number: +254-72-
721-781 or +254-2-729-549, Fax: +254-2-714-745, E-mail:
Lmarum@nairobi.mimcom.net.
Dated: July 17, 2001.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 01-18285 Filed 7-20-01; 8:45 am]
BILLING CODE 4163-18-P